South San Francisco, CA, United States of America

Neyssa Marina

This inventor holds 1 USPTO granted patent. Top assignee: Five Prime Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neyssa Marina. Retrieved from https://idiyas.com/inventor/neyssa-marina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neyssa Marina: Innovator in Cancer Therapy

Introduction

Neyssa Marina is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of cancer therapy through his innovative research and development efforts. His work focuses on combining therapies to enhance treatment efficacy for cancer patients.

Latest Patents

Neyssa Marina holds a patent titled "Combination Therapy for Cancer with Anti-B7-H4 Antibodies and Anti-PD-1 Antibodies." This patent represents a crucial advancement in cancer treatment, aiming to improve patient outcomes by utilizing a dual approach to target cancer cells more effectively. He has 1 patent to his name.

Career Highlights

Neyssa Marina is currently employed at Five Prime Therapeutics, Inc., where he continues to push the boundaries of cancer research. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking therapies that can change the landscape of cancer treatment.

Collaborations

One of his notable collaborators is Sandeep P Inamdar. Together, they work on innovative solutions that aim to improve the lives of cancer patients through advanced therapeutic strategies.

Conclusion

Neyssa Marina's contributions to cancer therapy exemplify the impact of innovative thinking in the medical field. His dedication to research and development continues to pave the way for new treatment options that can benefit countless individuals facing cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…